THE COST OF SLEEP DISORDERED BREATHING DIAGNOSIS IN ALBERTA

Similar documents
Appendix 1 (as supplied by the authors): Literature search

Portable Sleep Testing in Hospitalized Patients

Can we do it? Yes we can! Managing Obstructive Sleep Apnea in Primary Care. Dr Andrea Loewen MD, FRCPC, DABIM (Sleep)

SLEEP DISORDERED BREATHING The Clinical Conditions

Methods of Diagnosing Sleep Apnea. The Diagnosis of Sleep Apnea: Questionnaires and Home Studies

A profile of young Albertans with Fetal Alcohol Spectrum Disorder

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

Lipolysis and Metabolic Impairment in Community-Based Sample with Obstructive Sleep Apnea

POLICY All patients will be assessed for risk factors associated with OSA prior to any surgical procedures.

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods

Sleep and the Heart. Physiologic Changes in Cardiovascular Parameters during Sleep

Sleep and the Heart. Rami N. Khayat, MD

QUESTIONS FOR DELIBERATION

Chronic NIV in heart failure patients: ASV, NIV and CPAP

Obstructive sleep apnoea How to identify?

DECLARATION OF CONFLICT OF INTEREST

In-Patient Sleep Testing/Management Boaz Markewitz, MD

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

Background. Opportunity. The Proposed Study of e-mh for Youth and Young Adults

Prediction of sleep-disordered breathing by unattended overnight oximetry

Mario Kinsella MD FAASM 10/5/2016

Chronic Obstructive Lung Disease

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Auto Servo Ventilation Indications, Basics of Algorithm, and Titration

Contact-free Monitoring Technology for Screening of sleep

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Works Cited 1. A Quantitative Assessment of Sleep Laboratory Activity in the United States. Tachibana N, Ayas NT, White DP. 2005, J Clin Sleep Med,

Using Questionnaire Tools to Predict Pediatric OSA outcomes. Vidya T. Raman, MD Nationwide Children s Hospital October 201

Development of a portable device for home monitoring of. snoring. Abstract

Complete Sleep Apnea Care and Diabetes A Study on Total Cost Savings

18/06/2009 NZ Respiratory & Sleep Institute

Obstructive sleep apnea (OSA) is a common chronic respiratory

Epidemiology and diagnosis of sleep apnea

SLEEP APNEA IN THE ELDERLY SLEEP THAT KNITS UP THE RAVELED SLEEVE OF CARE

FAQ CODING & REIMBURSEMENT. WatchPAT TM Home Sleep Test

Alberta Transportation. Driver Fitness and Monitoring

Advocacy Strategy

OHTAC Recommendation: Chronic Obstructive Pulmonary Disease (COPD) Ontario Health Technology Advisory Committee

The pcodr review also provided contextual information on ALK mutation testing.

CHANGING SHAPE OF SLEEP STUDIES

CALGARY ZONE PULMONARY REFERRAL QUICK REFERENCE

Fabrice Czarnecki, M.D., M.A., M.P.H., FACOEM I have no disclosures to make.

A simple solution for your complex patients

Number: III-45 Effective Date: 1 February 2012 Revised Date: November 2016

Sleep Labs are Obsolete for Perioperative Assessment of Sleep-Disordered Breathing: Pro

Checklist for Completion of Training Requirements in Sleep Medicine Pathway 2

International Journal of Scientific & Engineering Research Volume 9, Issue 1, January ISSN

Alberta s Fire/Search and Rescue Safety Strategy

Waiting Your Turn. Wait Times for Health Care in Canada, 2018 Report. by Bacchus Barua and David Jacques. with Antonia Collyer

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

DECISION AND ORDER. After due notice, a telephone hearing was held on. , Medical Director, also testified as a witness for the MHP.

Health and Wellness Alberta Health Care Insurance Plan Statistical Supplement 2006/2007

Coding for Sleep Disorders Jennifer Rose V. Molano, MD

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines

Oral Appliances for Obstructive Sleep Apnea Response to Comments

pan-canadian Oncology Drug Review Initial Economic Guidance Report Osimertinib (Tagrisso) for Advanced or Metastatic Non-Small Cell Lung Cancer

Heart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows

National Sleep Disorders Research Plan

The Latest Technology from CareFusion

pan-canadian Oncology Drug Review Final Economic Guidance Report Ibrutinib (Imbruvica) for Mantle Cell Lymphoma July 19, 2016

Automated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

Sleep Quiz & Referral Form Inside

Assisted Reproductive Technologies

Chronic Pain Management Services in Newfoundland and Labrador. Provincial Chronic Pain Management Working Group. Discussion Document

Total Sleep Solution. Growing Cardiac Sleep Health Management. Together. Health Being Made Simple

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

Sleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016

Sleep Apnea: Diagnosis & Treatment

95% of care homes show clear care improvements1. Elevating Awareness & Creating Discussions Key 2016 Advocacy and Industry Efforts

Waiting Your Turn Wait Times for Health Care in Canada, 2017 Report

Positive Airway Pressure Systems for Sleep Disordered Breathing

Sleep Medicine. Paul Fredrickson, MD Director. Mayo Sleep Center Jacksonville, Florida.

Clinical Trials in OSA

Using a Café to Demystify Recommendations, Engage Audiences, and Address Barriers

Polysomnography (PSG) (Sleep Studies), Sleep Center

Sleep 101. Kathleen Feeney RPSGT, RST, CSE Business Development Specialist

Health Interventions in Ambulatory Cancer Care Centres

Multiple Criteria HTA Into Practice Local HTA Program. Innovation. Presenter: Paule Poulin, PhD CREATE OR DIE!

Victorian Model of Care for Osteoarthritis of the Hip and Knee

Enhancing Patient Care

Consolidated Comprehensive Research Plan: Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder in Adults

Central Sleep Apnoea during CPAP therapy First insights from a big data analysis. April 2018

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.

DATE: 07 August 2012 CONTEXT AND POLICY ISSUES

Technology Report. Auto-titrating Nasal Continuous Positive Airway Pressure Systems in the Management of Obstructive Sleep Apnea

September 6, Dear Centers for Medicare & Medicaid Services,

Respiratory/Sleep Disordered Breathing. William Walker, MD, Chair Iris Perez, MD

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS

EVIDENCE IN BRIEF OVERALL CLINICAL BENEFIT

In 1994, the American Sleep Disorders Association

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Peer Networks 101. The Role of a Statewide Network 07/31/2018. Cameron Wood, CRPS-A Executive Director Peer Support Coalition of Florida, Inc.

Alberta s Policies and Where We Are Now

Framework and Action Plan for Autism Spectrum Disorders Services in Saskatchewan. Fall 2008

SATA Patient Information Sheet. Detailed DVLA Guidance for UK Drivers with Sleep Apnoea

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2008, 59, Suppl 6,

Physician Dentist Collaboration

Transcription:

THE COST OF SLEEP DISORDERED BREATHING DIAGNOSIS IN ALBERTA Devidas Menon, Tania Stafinski & Alexa Nardelli Health Technology & Policy Unit 25 October 2013 Alberta Sleep Forum

CONFLICT OF INTEREST STATEMENT This work was made possible by a financial contribution from Alberta Health and Wellness and under the auspices of the Alberta Health Technologies Decision Process. The views expressed in this presentation do not necessarily represent the official policy of Alberta Health There are no other potential conflicts of interest to declare

BACKGROUND In 2003, the Expert Advisory Panel to Review Publicly Funded Health Services issued a report titled Burden of Proof The provincial government responded to the Panel s recommendations by establishing the Alberta Health Technologies Decision Process (AHTDP) Elements of the AHTDP are the Alberta Advisory Committee on Health Technologies, the Health Technologies and Services Policy Unit (Alberta Health), 3 research groups (Health Technology Assessment Partners) and Expert Advisory Groups.

From the Alberta Health website: The Decision Process involves the use of appropriate evidence and information for decision-making on the public funding of health technologies and services, with emphasis on technologies requiring review provincially or nationally. Through rigorous and timely review of selected health technologies, it contributes to the health outcomes of Albertans and a sustainable health system. The Decision Process, by bridging together research, public policy, and service delivery, allows the ministry and government to make evidenceinformed decisions about the funding of health services.

THE SDB REVIEW The objective of this review was intended to inform decisions regarding the provision of sleep studies in Alberta for diagnosing sleep disordered breathing Which sub-populations of SDB patients are most appropriately diagnosed with level I sleep studies, and which with level III studies? What are the effectiveness or efficacy, and safety, of level I and level III sleep studies for the diagnosis of SDB conditions? What are the social, ethical and legal considerations for the provision of level I and level III sleep studies for the diagnosis of SDB conditions? What are the fiscal and economic considerations for providing level I and level III sleep studies for the diagnosis of SDB conditions?

SCOPE OF THE REVIEW In this assessment sleep disordered breathing (SDB) includes the following disorders: obstructive sleep apnea upper airway resistance syndrome central sleep apnea Cheyne-Stokes respiration primary pulmonary disorders nocturnal hypoxia/hypoventilation bronchospasm

SDB EXPERT ADVISORY GROUP Dr. Adam Blackman (MedSleep) Ms. Reverdi Darda (Alberta Health Services, Zone Medicine Program, Ambulatory Care & RT Services) Dr. Paul Easton (University of Calgary, Critical Care Medicine) Dr. Ward Flemons (Alberta Health Services, Foothills Medical Centre) Dr. Irvin Mayers (University of Alberta, Division of Pulmonary Medicine) Dr. Brian McNab (University of Alberta, Edmonton Sleep Disorders Laboratory) Dr. Lawrence Pawluk, (University of Alberta, Department of Psychiatry, Sleep Medicine Program)

COST OF SDB DIAGNOSIS? Total cost of diagnosis = unit cost of each service x number of units provided, summed over all individual services Requires knowing (1) what each individual service is, (2) the cost of providing each one, and (3) the number of times each service is provided Data! Data! Data!

COST OF SDB DIAGNOSIS? Which patients do you include? How long a time frame do you want to know the costs for? Whose costs are you interested in?

COST OF SDB DIAGNOSIS? For policy purposes, what is required is an estimate of what it might cost the public purse to provide diagnostic services (with Level I and Level III testing) in what is deemed to be a clinically appropriate manner to patients in Alberta presenting with sleep disordered breathing This requires an economic model to be developed based on an appropriate clinical pathway This is called a budget impact analysis, and there are good practice guidelines for conducting such analyses

DATA FOR THE MODEL No. of patients presenting annually to a GP with SDB: 14,271 Source: BC physician payment data Cost data Initial GP visit $80 Follow-up GP visit for referral to specialist $44 Cost of initial specialist visit $226 Cost of level I test $1,642 Cost of in-home level III test $150 Sources: Alberta Health, expert opinion, vendor lists

DATA FOR THE MODEL Clinical data Fraction of sleep complaints due to suspected uncomplicated OSA 0.79 Fraction of patients dropping out before sleep test 0.06 Fraction of patients with complex disorders who have a level I test 0.80 Fraction of patients with complex disorders who have a level III test 0.20 Sources: clinical effectiveness review, expert opinion

DATA FOR THE MODEL Additional clinical data Probabilities of positive and negative results; probabilities of true and false positives; fractions of patients with repeat tests, etc. Sources: clinical effectiveness review, expert opinion

RESULTS The cost of treating 14,721 patients suspected of sleep disordered breathing will be $17, 420,000 at an AHI>15, and $10,490,000 at AHI>5 It will cost approximately $1,180 per patient at an AHI>15, and $710 at AHI>5

WHAT NEXT? A synthesis document is being prepared by Alberta Health This and the complete review will be discussed by the EAG Policy recommendations will be formulated for consideration by the AACHT AACHT will make a recommendation to the ministry

Full version of the review report (available now): Level I and Level III Sleep Studies for the Diagnosis of Sleep Disordered Breathing (SDB) in Adults (2013) http://www.health.alberta.ca/initiatives/ahtdp-completed-reviews.html Published manuscript on the clinical review (available 4 November): Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis. Canadian Medical Association Journal. El Shayeb M, Topfer L-A, Stafinski T, Pawluk L, Menon D.